Status:
COMPLETED
Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
30-75 years
Phase:
PHASE2
Brief Summary
India is the "Diabetes Capital of the World" with 41 million Indians having diabetes i.e. every fifth diabetic in the world is an Indian1. Type 2 Diabetes Mellitus (T2DM) constitutes the major chunk o...
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes mellitus more than 30 and less than 75 years of age.
- Insulin requirement 0.7 IU/kg/d or 50 IU/d, whichever is lesser.
- GAD antibody negative status.
Exclusion
- Patients with T1DM or secondary diabetes.
- Patients with serum creatinine \> 1.5 mg/dl.
- Abnormal liver function tests (defined as value of transaminases \> 3 times the upper value of normal or serum bilirubin higher than normal for the reference value for the laboratory).
- History of myocardial infarction or unstable angina in the previous 3 months.
- History of malignancy or current malignancy other than non-melanomatous skin cancer.
- Patients with active infections
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00644241
Start Date
January 1 2008
End Date
June 1 2009
Last Update
October 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pgimer
Chandigarh, Chandigarh, India